Franz Matschinsky

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi Glucokinase, glucose homeostasis, and diabetes mellitus
    Franz M Matschinsky
    University of Pennsylvania Medical School, Department of Biochemistry and Biophysics, 501 Stemmler Hall, 36th and Hamilton Walk, Philadelphia, PA 19104, USA
    Curr Diab Rep 5:171-6. 2005
  2. ncbi The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy
    Franz M Matschinsky
    University of Pennsylvania, Department of Biochemistry and Biophysics, 501 Stemmler Hall, Philadelphia, PA 19104, USA
    Diabetes 55:1-12. 2006
  3. ncbi Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics
    Nicolai M Doliba
    Department of Biochemistry and Biophysics, University of Pennsylvania, 415 Curie Blvd, Philadelphia, PA 19104 6140, USA
    Am J Physiol Endocrinol Metab 302:E87-E102. 2012
  4. ncbi Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics
    Franz M Matschinsky
    Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Diabetes 51:S394-404. 2002
  5. ncbi Assessing the potential of glucokinase activators in diabetes therapy
    Franz M Matschinsky
    University of Pennsylvania, School of Medicine, Department of Biochemistry and Biophysics, 612 Clinical Research Building, Philadelphia, Pennsylvania 19104, USA
    Nat Rev Drug Discov 8:399-416. 2009
  6. ncbi A signaling role of glutamine in insulin secretion
    Changhong Li
    Division of Endocrinology, Children s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA
    J Biol Chem 279:13393-401. 2004
  7. ncbi Foxa2 regulates multiple pathways of insulin secretion
    Kristen A Lantz
    Department of Genetics, Children s Hospital of Philadelphia, Philadelphia, PA, USA
    J Clin Invest 114:512-20. 2004
  8. ncbi Pharmacologically regulated regeneration of functional human pancreatic islets
    Gary P Kobinger
    Gene Therapy Program, Division of Medical Genetics, Department of Medicine, University of Pennsylvania Health System, Philadelphia, PA 19104, USA
    Mol Ther 11:105-11. 2005
  9. ncbi Exendin-(9-39) corrects fasting hypoglycemia in SUR-1-/- mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion
    Diva D De Leon
    Division of Endocrinology, Department of Pediatrics, The Children s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA
    J Biol Chem 283:25786-93. 2008
  10. ncbi The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion
    Rana K Gupta
    Department of Genetics, Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    J Clin Invest 115:1006-15. 2005

Research Grants

  1. METABOLISM OF ISLETS OF LANGERHANS AND HORMONE RELEASE
    Franz M Matschinsky; Fiscal Year: 2010
  2. METABOLISM OF ISLETS OF LANGERHANS AND HORMONE RELEASE
    Franz Matschinsky; Fiscal Year: 2007
  3. METABOLISM OF ISLETS OF LANGERHANS AND HORMONE RELEASE
    Franz Matschinsky; Fiscal Year: 2006
  4. METABOLISM OF ISLETS OF LANGERHANS AND HORMONE RELEASE
    Franz Matschinsky; Fiscal Year: 2002

Collaborators

Detail Information

Publications46

  1. ncbi Glucokinase, glucose homeostasis, and diabetes mellitus
    Franz M Matschinsky
    University of Pennsylvania Medical School, Department of Biochemistry and Biophysics, 501 Stemmler Hall, 36th and Hamilton Walk, Philadelphia, PA 19104, USA
    Curr Diab Rep 5:171-6. 2005
    ..There is no question that the GK molecule and related issues will continue to be a fruitful topic for future research...
  2. ncbi The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy
    Franz M Matschinsky
    University of Pennsylvania, Department of Biochemistry and Biophysics, 501 Stemmler Hall, Philadelphia, PA 19104, USA
    Diabetes 55:1-12. 2006
    ..Future biophysical, molecular, genetic, and pharmacological studies hold much promise to unravel the evolving complexity of the glucokinase glucose sensor system...
  3. ncbi Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics
    Nicolai M Doliba
    Department of Biochemistry and Biophysics, University of Pennsylvania, 415 Curie Blvd, Philadelphia, PA 19104 6140, USA
    Am J Physiol Endocrinol Metab 302:E87-E102. 2012
    ..Our data suggest that impaired ?-cell bioenergetics resulting in greatly reduced ATP production is critical in the molecular pathogenesis of type 2 diabetes mellitus...
  4. ncbi Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics
    Franz M Matschinsky
    Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Diabetes 51:S394-404. 2002
    ..The therapeutic application of this basic discovery offers a new principle for drug therapy of diabetes...
  5. ncbi Assessing the potential of glucokinase activators in diabetes therapy
    Franz M Matschinsky
    University of Pennsylvania, School of Medicine, Department of Biochemistry and Biophysics, 612 Clinical Research Building, Philadelphia, Pennsylvania 19104, USA
    Nat Rev Drug Discov 8:399-416. 2009
    ..Here, the scientific basis and current status of this new approach to diabetes therapy are discussed...
  6. ncbi A signaling role of glutamine in insulin secretion
    Changhong Li
    Division of Endocrinology, Children s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA
    J Biol Chem 279:13393-401. 2004
    ....
  7. ncbi Foxa2 regulates multiple pathways of insulin secretion
    Kristen A Lantz
    Department of Genetics, Children s Hospital of Philadelphia, Philadelphia, PA, USA
    J Clin Invest 114:512-20. 2004
    ..Thus, we have established Foxa2 as an essential activator of genes that function in multiple pathways governing insulin secretion...
  8. ncbi Pharmacologically regulated regeneration of functional human pancreatic islets
    Gary P Kobinger
    Gene Therapy Program, Division of Medical Genetics, Department of Medicine, University of Pennsylvania Health System, Philadelphia, PA 19104, USA
    Mol Ther 11:105-11. 2005
    ..This strategy has the potential to reduce the quantity of human islets required for treatment of patients with Type I diabetes...
  9. ncbi Exendin-(9-39) corrects fasting hypoglycemia in SUR-1-/- mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion
    Diva D De Leon
    Division of Endocrinology, Department of Pediatrics, The Children s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA
    J Biol Chem 283:25786-93. 2008
    ..Our findings indicate that exendin-(9-39) normalizes fasting hypoglycemia in SUR-1(-/-) mice via a direct effect on insulin secretion, thereby raising exendin-(9-39) as a potential therapeutic agent for K(ATP) hyperinsulinism...
  10. ncbi The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion
    Rana K Gupta
    Department of Genetics, Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    J Clin Invest 115:1006-15. 2005
    ..Our data provide genetic evidence that HNF-4alpha is required in the pancreatic beta cell for regulation of the pathway of insulin secretion dependent on the ATP-dependent potassium channel...
  11. ncbi Effects of a GTP-insensitive mutation of glutamate dehydrogenase on insulin secretion in transgenic mice
    Changhong Li
    Division of Endocrinology, The Children's Hospital of Philadelphia and Diabetes Center, Philadelphia, Pennsylvania 19104, USA
    J Biol Chem 281:15064-72. 2006
    ..This study suggests that GDH functions predominantly in the direction of glutamate oxidation rather than glutamate synthesis in mouse islets and that this flux is tightly controlled by glucose...
  12. ncbi Distinguishing features of leucine and alpha-ketoisocaproate sensing in pancreatic beta-cells
    Zhiyong Gao
    Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine and The Children's Hospital, Philadelphia, Pennsylvania 19104, USA
    Endocrinology 144:1949-57. 2003
    ..In conclusion, leucine and KIC stimulated beta-cells via distinct mechanisms. Glutamate dehydrogenase is the sensor of leucine, whereas transamination plays an important role in KIC stimulation of pancreatic beta-cells...
  13. ncbi Regulation of leucine-stimulated insulin secretion and glutamine metabolism in isolated rat islets
    Changhong Li
    Division of Endocrinology, Children's Hospital of Philadelphia, Pennsylvania 19104, USA
    J Biol Chem 278:2853-8. 2003
    ..These mechanisms provide an explanation for hypoglycemia caused by mutations of GDH in children...
  14. ncbi Insulin independence following isolated islet transplantation and single islet infusions
    James F Markmann
    Department of Surgery, University of Pennsylvania Health System, Hospital of the University of Pennsylvania, 4th Floor Silverstein, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Ann Surg 237:741-9; discussion 749-50. 2003
    ..To restore islet function in patients whose labile diabetes subjected them to frequent dangerous episodes of hypoglycemic unawareness, and to determine whether multiple transplants are always required to achieve insulin independence...
  15. ncbi The use of non-heart-beating donors for isolated pancreatic islet transplantation
    James F Markmann
    Department of Surgery, University of Pennsylvania Health System, Philadelphia 19104, USA
    Transplantation 75:1423-9. 2003
    ..These results indicate that NHBDs may provide an as yet untapped source of pancreatic tissue for preparation of isolated islets for clinical transplantation...
  16. ncbi Analysis of gene expression in pancreatic islets from diet-induced obese mice
    Yumi Imai
    Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Physiol Genomics 36:43-51. 2008
    ..Functional analyses of differentially regulated genes hold promise for elucidating factors linking obesity to alterations in islet function...
  17. ncbi Cholinergic regulation of fuel-induced hormone secretion and respiration of SUR1-/- mouse islets
    Nicolai M Doliba
    Dept of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Am J Physiol Endocrinol Metab 291:E525-35. 2006
    ....
  18. ncbi Foxa1-deficient mice exhibit impaired insulin secretion due to uncoupled oxidative phosphorylation
    Marko Z Vatamaniuk
    Department of Genetics and Institute of Diabetes, Obesity and Metabolism, University of Pennsylvania School of Medicine, 415 Curie Blvd, Philadelphia, PA 19104 6145, USA
    Diabetes 55:2730-6. 2006
    ..Chromatin immunoprecipitation assays indicate that UCP2 is a direct transcriptional target of Foxa1 in vivo. Thus, we have identified a novel function for Foxa1 in the regulation of oxidative phosphorylation in pancreatic beta-cells...
  19. ncbi Metabolic and ionic coupling factors in amino acid-stimulated insulin release in pancreatic beta-HC9 cells
    Nicolai M Doliba
    Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, PA, USA
    Am J Physiol Endocrinol Metab 292:E1507-19. 2007
    ....
  20. ncbi Elimination of KATP channels in mouse islets results in elevated [U-13C]glucose metabolism, glutaminolysis, and pyruvate cycling but a decreased gamma-aminobutyric acid shunt
    Changhong Li
    Division of Endocrinology, The Children s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Biol Chem 283:17238-49. 2008
    ....
  21. ncbi Palmitic acid acutely inhibits acetylcholine- but not GLP-1-stimulated insulin secretion in mouse pancreatic islets
    Nicolai M Doliba
    Department of Biochemistry and Biophysics and Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, 19104 6140, USA
    Am J Physiol Endocrinol Metab 299:E475-85. 2010
    ..We speculate that acute emptying of the ER calcium by PA results in decreased glucose stimulation of respiration and acetylcholine potentiation of insulin secretion...
  22. ncbi Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase
    Changhong Li
    Division of Endocrinology, The Children s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA
    J Biol Chem 285:31806-18. 2010
    ..These studies indicate that SCHAD deficiency causes hyperinsulinism by activation of GDH via loss of inhibitory regulation of GDH by SCHAD...
  23. ncbi Insulin secretion is increased in pancreatic islets of neuropeptide Y-deficient mice
    Yumi Imai
    Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Endocrinology 148:5716-23. 2007
    ....
  24. ncbi Restitution of defective glucose-stimulated insulin release of sulfonylurea type 1 receptor knockout mice by acetylcholine
    Nicolai M Doliba
    Diabetes Research Center, Department of Biochemistry and Biophysics, Univ of Pennsylvania, Philadelphia, PA 19104 6015, USA
    Am J Physiol Endocrinol Metab 286:E834-43. 2004
    ..Priming by the combination of high [Ca2+]i, ACh, and GLP-1 restores the defective glucose responsiveness, precluding the development of diabetes but not effectively enough to cause hyperinsulinemic hypoglycemia...
  25. ncbi Differential effects of glucose and glyburide on energetics and Na+ levels of betaHC9 cells: nuclear magnetic resonance spectroscopy and respirometry studies
    Nicolai M Doliba
    Diabetes Research Center and Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia 19104, USA
    Diabetes 52:394-402. 2003
    ....
  26. ncbi Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets
    Ewan Bell
    Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104-4399, USA
    Diabetes 52:2731-9. 2003
    ....
  27. ncbi A glucose sensor role for glucokinase in anterior pituitary cells
    Dorothy Zelent
    University of Pennsylvania School of Medicine, BiochemistryBiophysics, 501 Stemmler Hall, 36th and Hamilton Walk, Philadelphia, PA 19104, USA
    Diabetes 55:1923-9. 2006
    ....
  28. ncbi Extremes of clinical and enzymatic phenotypes in children with hyperinsulinism caused by glucokinase activating mutations
    Samir Sayed
    Clinical Translational Research Center, Children s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
    Diabetes 58:1419-27. 2009
    ..We report three children with de novo glucokinase hyperinsulinism mutations who displayed a spectrum of clinical phenotypes corresponding to marked differences in enzyme kinetics...
  29. ncbi Glutaminolysis and insulin secretion: from bedside to bench and back
    Andrea Kelly
    Department of Pediatrics, Children s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Diabetes 51:S421-6. 2002
    ..These findings provide a foundation for defining pathways of basal secretion and AASIS, augmenting our understanding of beta-cell function...
  30. ncbi Foxa2 controls Pdx1 gene expression in pancreatic beta-cells in vivo
    Catherine S Lee
    Department of Genetics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 6145, USA
    Diabetes 51:2546-51. 2002
    ..These data represent the first in vivo demonstration that Foxa2 acts upstream of Pdx1 in the differentiated beta-cell...
  31. ncbi Transduction of human islets with pseudotyped lentiviral vectors
    Gary P Kobinger
    Gene Therapy Program, Division of Medical Genetics, Department of Medicine, University of Pennsylvania Health System, Philadelphia, PA 19104, USA
    Hum Gene Ther 15:211-9. 2004
    ..Overall, our study describes an improved methodology for achieving safe and efficient gene transfer into cells of human islets...
  32. ncbi Foxa2 controls vesicle docking and insulin secretion in mature Beta cells
    Nan Gao
    Department of Genetics, University of Pennsylvania, Philadelphia, PA 19104, USA
    Cell Metab 6:267-79. 2007
    ..We conclude that Foxa2 is required for both fetal pancreas development and the function of mature beta cells...
  33. ncbi Functional genomics of the beta-cell: short-chain 3-hydroxyacyl-coenzyme A dehydrogenase regulates insulin secretion independent of K+ currents
    Olga T Hardy
    Department of Genetics, University of Pennsylvania School of Medicine, 415 Curie Boulevard, 560 Clinical Research Building, Philadelphia, Pennsylvania 19104, USA
    Mol Endocrinol 21:765-73. 2007
    ..Our results suggest a molecular explanation for the hyperinsulinemia hypoglycemic seen in patients with SCHAD deficiency...
  34. ncbi Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects
    Shaoping Deng
    Department of Surgery, Harrison Department of Surgical Research, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Diabetes 53:624-32. 2004
    ..These results provide direct evidence for abnormalities in the islets of type 2 diabetic patients that may contribute to the pathogenesis of the disease...
  35. ncbi Sugar binding to recombinant wild-type and mutant glucokinase monitored by kinetic measurement and tryptophan fluorescence
    Bogumil Zelent
    Department of Biochemistry and Biophysics and Diabetes Research Center, University of Pennsylvania, Philadelphia, PA 19104, USA
    Biochem J 413:269-80. 2008
    ....
  36. ncbi The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy
    Henrik B T Christesen
    Department of Pediatrics, Odense University Hospital, Odense, Denmark
    Diabetes 51:1240-6. 2002
    ..Mathematical modeling predicted a markedly lowered GSIR threshold of 1.5 mmol/l. The theoretical and practical implications are manifold and significant...
  37. ncbi Allosteric activators of glucokinase: potential role in diabetes therapy
    Joseph Grimsby
    Department of Metabolic Diseases, Hoffmann-La Roche Inc, Nutley, NJ 07110, USA
    Science 301:370-3. 2003
    ..These findings may lead to the development of new drug therapies for diabetes...
  38. ncbi Protein kinase A translocation and insulin secretion in pancreatic beta-cells: studies with adenylate cyclase toxin from Bordetella pertussis
    Zhiyong Gao
    Department of Pathology and Laboratory Medicine, Children s Hospital of Philadelphia and University of Pennsylvania School of Medicine, 5135 Main Building, 34th Street and Civic Center Blvd, Philadelphia, PA 19104 4399, U S A
    Biochem J 368:397-404. 2002
    ..In conclusion, glucose and GLP-1 amplify insulin secretion via cAMP production and PKAbeta activation...
  39. ncbi Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young
    Anna L Gloyn
    Diabetes Research Laboratories, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LJ, United Kingdom
    J Biol Chem 280:14105-13. 2005
    ..Elucidating such mechanisms leads to a deeper understanding of the GCK glucose sensor and the biochemistry of beta-cells and hepatocytes...
  40. ncbi Glucokinase thermolability and hepatic regulatory protein binding are essential factors for predicting the blood glucose phenotype of missense mutations
    Maria F Pino
    Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA
    J Biol Chem 282:13906-16. 2007
    ....
  41. ncbi Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway
    Pål R Njølstad
    Department of Pediatrics, Haukeland University Hospital, University of Bergen, Norway
    Diabetes 52:2854-60. 2003
    ..Autosomal recessive inheritance and enzyme deficiency are features typical for an inborn error of metabolism, which occurred in the glucose-insulin signaling pathway in these subjects...
  42. ncbi Green tea polyphenols modulate insulin secretion by inhibiting glutamate dehydrogenase
    Changhong Li
    Donald Danforth Plant Science Center, 975 Warson Road, St. Louis, MO 63132, USA
    J Biol Chem 281:10214-21. 2006
    ..These results demonstrate that EGCG, much like the activator of GDH (BCH), can facilitate dissecting the complex regulation of insulin secretion by pharmacologically modulating the effects of GDH...
  43. ncbi Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations
    Anna L Gloyn
    Department of Diabetes and Vascular Medicine, Peninsula Medical School, Exeter, UK
    Diabetes 52:2433-40. 2003
    ..In vitro studies confirm the validity of structural and functional models of GCK and the putative allosteric activator site, which is a potential drug target for the treatment of type 2 diabetes...
  44. ncbi Immunohistochemical evidence for the presence of glucokinase in the gonadotropes and thyrotropes of the anterior pituitary gland of rat and monkey
    Robert L Sorenson
    Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, USA
    J Histochem Cytochem 55:555-66. 2007
    ....
  45. ncbi Cell biology assessment of glucokinase mutations V62M and G72R in pancreatic beta-cells: evidence for cellular instability of catalytic activity
    Catherine Arden
    Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
    Diabetes 56:1773-82. 2007
    ..These results suggest that cellular loss of GK catalytic activity rather than impaired translation or enhanced protein degradation may account for the hyperglycemia in subjects with V62M and G72R mutations...

Research Grants17

  1. METABOLISM OF ISLETS OF LANGERHANS AND HORMONE RELEASE
    Franz M Matschinsky; Fiscal Year: 2010
    ..3) Explore the biochemistry and physiological significance of glucokinase in gonadotropes and thyrotropes of the pituitary gland to help understand the extra-pancreatic and extra-hepatic role of the enzyme. ..
  2. METABOLISM OF ISLETS OF LANGERHANS AND HORMONE RELEASE
    Franz Matschinsky; Fiscal Year: 2007
    ..3) Explore the biochemistry and physiological significance of glucokinase in gonadotropes and thyrotropes of the pituitary gland to help understand the extra-pancreatic and extra-hepatic role of the enzyme. ..
  3. METABOLISM OF ISLETS OF LANGERHANS AND HORMONE RELEASE
    Franz Matschinsky; Fiscal Year: 2006
    ....
  4. METABOLISM OF ISLETS OF LANGERHANS AND HORMONE RELEASE
    Franz Matschinsky; Fiscal Year: 2002
    ....